OPEN-ANGLE GLAUCOMA
Clinical trials for OPEN-ANGLE GLAUCOMA explained in plain language.
Never miss a new study
Get alerted when new OPEN-ANGLE GLAUCOMA trials appear
Sign up with your email to follow new studies for OPEN-ANGLE GLAUCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo eye drop may offer Round-the-Clock glaucoma relief
Disease control Recruiting nowThis study tests whether a combination eye drop (Rocklatan) lowers eye pressure better over a full day than a standard drop (Latanoprost) in people with open-angle glaucoma or high eye pressure. About 30 adults will use one drop of each medicine in different eyes nightly. The goa…
Matched conditions: OPEN-ANGLE GLAUCOMA
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New eye injection aims to tame glaucoma pressure
Disease control Recruiting nowThis study tests an experimental eye injection called AGN-193408 SR in people with open-angle glaucoma or high eye pressure. The goal is to see if it safely lowers pressure inside the eye, which can prevent vision loss. About 96 adults who have had cataract surgery at least 4 mon…
Matched conditions: OPEN-ANGLE GLAUCOMA
Phase: PHASE1, PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New implant combo may replace risky glaucoma surgery
Disease control Recruiting nowThis study tests whether two small devices placed inside the eye can safely lower eye pressure in people with moderate to severe open-angle glaucoma. The devices are an alternative to traditional filtering surgery. The study will enroll 20 adults whose glaucoma is not well contro…
Matched conditions: OPEN-ANGLE GLAUCOMA
Phase: PHASE4 • Sponsor: Jonathon Myers • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
New laser device takes on glaucoma during cataract surgery
Disease control Recruiting nowThis study compares two devices, ELIOS and a competitor, used during cataract surgery to lower eye pressure in people with open-angle glaucoma. About 194 adults aged 40 and older with mild to moderate glaucoma and cataracts will take part. The main goal is to see which device wor…
Matched conditions: OPEN-ANGLE GLAUCOMA
Phase: NA • Sponsor: Elios Vision, Inc. • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
Five-Year test for new glaucoma implant aims to protect vision
Disease control Recruiting nowThis study is monitoring the long-term safety and effectiveness of the XEN45 implant, a tiny device placed in the eye to lower pressure. It is comparing the implant to a standard glaucoma surgery (trabeculectomy) in about 130 adults in China who have open-angle glaucoma. The main…
Matched conditions: OPEN-ANGLE GLAUCOMA
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 13, 2026 20:16 UTC
-
Eye drop alternative injection studied for gentler glaucoma care
Knowledge-focused Recruiting nowThis study looks at whether a slow-release eye injection (Durysta) can reduce eye surface inflammation caused by daily glaucoma eye drops. Researchers will measure a marker of inflammation (caspase-1) in 20 adults with open-angle glaucoma or high eye pressure. The goal is to see …
Matched conditions: OPEN-ANGLE GLAUCOMA
Phase: PHASE4 • Sponsor: University of Miami • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Glaucoma surgery: does it improve how you see and live?
Knowledge-focused Recruiting nowThis study looks at how different types of glaucoma surgery affect patients' quality of life, not just eye pressure. About 132 adults having surgery will fill out questionnaires before and 6 months after their operation. The goal is to understand what matters most to patients, in…
Matched conditions: OPEN-ANGLE GLAUCOMA
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC